LENZ TherapeuticsLENZ

那斯達克 · USD
17.08
-1.06
(-5.84%)
收盤 12/16 04:59 (UTC+8)
盤後 
17.62 
+0.54 
(+3.16%)
12/16 04:59 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • 0.05
  • 0.13
icon
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • 150.00
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
2023/Q3
2023/Q2
營業收入淨額
12,500
5,000
-
-
-
-
-
-
-
-
營業成本
----------
營業毛利
12,500
5,000
-
-
-
-
-
-
-
-
營業費用
31,38721,85716,93115,22512,945-16,08887,75182,06171,993
研發費用
3,7919,0615,8185,8686,4516,94510,537-7,8319,17219,427
推銷及管理費用
27,59612,79611,1139,3576,4947,4075,55133,50121,76112,787
非經常性項目費用
-------62,08151,12839,779
其他營業費用
----------
營業利益
-18,887
-16,857
-16,931
-15,225
-12,945
-14,352
-16,088
-87,751
-82,061
-71,993
其他收入及費用
2,1872,4452,3122,5742,7304,098-5609,3767,7245,415
利息費用
----------
稅前純益
-16,700
-14,412
-14,619
-12,651
-10,215
-10,254
-16,648
-78,375
-74,337
-66,578
所得稅
-500-1------
稅後純益
-16,700
-14,912
-14,619
-12,652
-10,215
-10,254
-16,648
-78,375
-74,337
-66,578
基本每股稅後盈餘(元)
-0.59-0.53-0.53-0.46-0.38-0.40-3.53--0.11-0.08
稀釋每股稅後盈餘(元)
-0.59-0.53-0.53-0.41-0.161.76-3.53-1.72-1.38-1.07
基本平均股數(千股)
28540.0028079.0027526.0027492.0027172.0025608.004717.00-178734.00178734.00
稀釋平均股數(千股)
28540.0028079.0027526.0027492.0027172.0025608.004717.00-178734.00178734.00
還原基本每股稅後盈餘(元)
-0.59-0.53-0.53-0.46-0.38-0.40-3.53--0.74-0.58
還原稀釋每股稅後盈餘(元)
-0.59-0.53-0.53-0.41-0.161.76-3.53-12.05-9.64-7.52
還原基本平均股數(千股)
28,54028,07927,52627,49227,17225,6084,717-25,53325,533
還原稀釋平均股數(千股)
28,54028,07927,52627,49227,17225,6084,717-25,53325,533
EBITDA(千元)
-17,354-15,281-15,717-14,050-11,564-11,195-16,918-73,890-75,482-67,544

大家都在看

HOT